Newly Diagnosed Primary Open-Angle Glaucoma Randomized to 2 Trabecular Bypass Stents or Prostaglandin: Outcomes Through 36 Months

@inproceedings{Vold2016NewlyDP,
  title={Newly Diagnosed Primary Open-Angle Glaucoma Randomized to 2 Trabecular Bypass Stents or Prostaglandin: Outcomes Through 36 Months},
  author={Steven D. Vold and Lilit Voskanyan and Manfred R. Tetz and Gerd Uwe Auffarth and Imran Masood and Leon Au and Iqbal Ike Karim Ahmed and Hady Saheb},
  booktitle={Ophthalmology and therapy},
  year={2016}
}
PURPOSE To examine outcomes through 36 months in phakic eyes with newly diagnosed primary open-angle glaucoma (POAG) naïve to therapy randomized to treatment with two trabecular micro-bypass stents or topical prostaglandin. METHODS Subjects with POAG naïve to therapy, with intraocular pressure (IOP) ≥21 and ≤40 mmHg, were randomized to implantation of two stents or travoprost. Additional medication was to be prescribed post-treatment for elevated IOP or glaucomatous optic nerve findings. Of… CONTINUE READING